Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 18Prostatic Neoplasms 16Colorectal Neoplasms 14Neoplasms 12Hematopoietic and Lymphatic System Neoplasm 12Lung Neoplasms 9Hematologic Neoplasms 8Ovarian Neoplasms 5Multiple Myeloma 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Malignant Solid Neoplasm 4Lymphoma 4Urinary Bladder Neoplasms 3Hematopoietic and Lymphoid System Neoplasm 3Advanced Malignant Solid Neoplasm 3Triple Negative Breast Neoplasms 2Thyroid Cancer, Papillary 2Pancreatic Neoplasms 2Oropharyngeal Neoplasms 2Obesity-Related Malignant Neoplasm 2Mouth Neoplasms 2Motor Activity 2Melanoma 2Malignant Female Reproductive System Neoplasm 2Leukemia, Myeloid, Acute 2Leukemia 2Laryngeal Neoplasms 2Hypopharyngeal Neoplasms 2Head and Neck Neoplasms 2Genetic Predisposition to Disease 2

Interventions

Standard of Care 1Interviews as Topic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
ACT-GEN × Interviews as Topic × 1 year × Clear all
NCT07565467 2026-05-04

ACT-GEN (Adherence And Care Tracking In GENetic Cancer Syndromes)

M.D. Anderson Cancer Center

Phase NA Not yet recruiting
80 enrolled

ACT-GEN

Data powered by HemOnc (CC BY 4.0) Colophon âš¡